TH1 and TH2 responses are influenced by HLA antigens in healthy neonates vaccinated with recombinant hepatitis B vaccine

Iranian Journal of Allergy, Asthma and Immunology

Volumn 11, Issue 4, 2012, Pages 308-315

  Jafarzadeh, Abdollah ^a,b   Shokri, Fazel ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

Cytokine; Hepatitis B vaccine; HLA antigens

Indexed keywords

GAMMA INTERFERON; HEBERBIOVAC; HEPATITIS B SURFACE ANTIGEN; HLA A2 ANTIGEN; HLA B7 ANTIGEN; HLA DQ2 ANTIGEN; HLA DR ANTIGEN; HLA DR53 ANTIGEN; HLA DR7 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MITOGENIC AGENT; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HAPLOTYPE; HEPATITIS B; HUMAN; HUMAN TISSUE; INFANT; LYMPHOCYTOTOXICITY; NEWBORN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; TH1 CELL; TH2 CELL; VACCINATION;

CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNIZATION; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; IRAN; MALE; PHENOTYPE; TH1 CELLS; TH2 CELLS; VACCINES, DNA;

EID: 84872435924     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Jafarzadeh A, Zarei S, Shokri F. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Vaccine 2008; 26(2):269-76. (Pubitemid 350266123)
2. Baghianimoghadam MH, Shadkam MN, Hadinedoushan H. Immunity to hepatitis B vaccine among health care workers. Vaccine 2011; 29(15):2727-9.
3. Agladioglu S, Beyazova U, Camurdan AD, Sahin F, Atak A. Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules. Infection 2010; 38(4):269-73.
4. Desombere I, Gijbels Y, Verwulgen A, Leroux-Roels G. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines. Clin Exp Immunol 2000; 122(3):390-9. (Pubitemid 32002197)
5. Jafarzadeh A, Shokrgozar MA, Khoshnoodi J, Shokri F. Unresponsiveness to recombinant hepatitis B vaccine in healthy Iranian neonates: association with HLA antigens. Irn J Med Sci 2002; 27(2):51-5. (Pubitemid 36004789)
6. Amirzargar AA, Mohseni N, Shokrgozar MA, Arjang Z, Ahmadi N, Yousefi Behzadi M, et al. HLA-DRB1, DQA1 and DQB1 alleles and haplotypes frequencies in Iranian healthy adult responders and non-responders to recombinant hepatitis B vaccine. Iran J Immunol 2008; 5(2):92-9. (Pubitemid 351845538)
7. Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 2005; 41(6):1383-90. (Pubitemid 40774886)
8. Vingerhoets J, Vanham G, Kestens L, Penne G, Leroux-Roels G, Gigase P. Deficient T-cell response in nonresponders to hepatitis B vaccination: absence of TH1 cytokine production. Immunol lett 1994; 39(2):163-8. (Pubitemid 24131323)
9. Chedid MG, Deulofeut H, Yunis DE, Lara-Marquez ML, Salazar M, Deulofeut R, et al. Defect in Th1-like cells of non-responders to hepatitis B vaccine. Hum Immunol 1997; 58(1):42-51. (Pubitemid 28027412)
10. Livingston BD, Alexander J, Crimi C, Oseroff C, Celis E, Daly K, et al. Altered helper T-lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in human. J Immunol 1999; 162(5):3088-95. (Pubitemid 29309340)
11. Velu V, Saravanan S, Nandakumar S, Shankar EM, Vengatesan A, Jadhav SS, et al. Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines. World J Gastroenterol 2008; 14(22):3534-40.
12. Kardar GA, Jeddi-Tehrani M, Shokri F. Diminished Th1 and Th2 cytokine production in healthy adult non-responders to recombinant hepatitis B vaccine. Scand J Immunol 2002; 55(3):311-4. (Pubitemid 34310036)
13. Honorati MC, Dolzani P, Mariani E, Piacentini A, Lisignoli G, Ferrari C, et al. Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine. Gastroenterology 1997; 112(6):2017-27. (Pubitemid 27240789)
14. Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Whittle H, Lambert PH, et al. Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. Vaccine 2004; 22(3-4):511-9. (Pubitemid 37510283)
15. Wataya M, Sano T, Kamikawaji N, Tana T, Yamamoto K, Sasazuki T, et al. Comparative analysis of HLA restriction and cytokine production in hepatitis B surface antigen-specific T-cells from low-and high- antibody responders in vaccinated humans. J Hum Genet 2001; 46(4):197-206. (Pubitemid 32435603)
16. Jafarzadeh A, Shokri F. The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates. Clin Exp Immunol 2003, 131(3):451-6. (Pubitemid 36324136)
17. Shokrgozar MA, Shokri F. HLA-associated antibody response to recombinant hepatitis B vaccine in healthy Iranian adults. Irn J Med Sci 1999; 24:98-103. (Pubitemid 30232882)
18. Jafarzadeh A, Kardar GA, Khoshnoodi J, Shokri F. Downregulation of IL-12 production in healthy non-responder neonates to recombinant hepatitis B vaccine. Irn Biomed J 2004; 8(1):41-5.
19. Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, et al. Clear and independent associations of several HLADRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet 2009; 126(5):685-96.
20. Das K, Gupta RK, Kumar V, Singh S, Kar P. Association of HLA phenotype with primary non-response to recombinant hepatitis B vaccine: a study from north India. Trop Gastroenterol 2004; 25(3):113-5.
21. Fletcher GJ, Samuel P, Christdas J, Gnanamony M, Ismail AM, Anantharam R, et al. Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population. Genes Immun 2011; 12(7):552-8.
22. Kruger A, Adams P, Hammer J, Böcher WO, Schneider PM, Rittner C, et al. Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies. Clin Exp Immunol 2005; 140(2):325-32. (Pubitemid 40559160)
23. Desombere I, Gijbels Y, Verwulgen A. Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccine. Clin Exp Immunol 2000; 122(3):390-9. (Pubitemid 32002197)
24. Desombere I, Cao T, Gijbels Y, Leroux-Roels G. Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation. Clin Exp Immunol 2005; 140(1):126-37. (Pubitemid 40461082)
25. Avanzini MA, Belloni C, De Silvestri A, Castellazzi AM, Marconi M, Moretta A, et al. Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity. Clin Immunol 2003; 107(2):122-8. (Pubitemid 36579376)
26. Wataya M, Sano T, Kamikawaji N, Tana T, Yamamoto K, Sasazuki T. Comparative analysis of HLA restriction and cytokine production in hepatitis B surface antigen-specific T-cells from low-and high- antibody responders in vaccinated humans. J Hum Genet 2001; 46(4):197-206. (Pubitemid 32435603)
27. Desombere I, Cao T, Gijbels Y, Leroux-Roels G. Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation. Clin Exp Immunol 2005; 140(1):126-37. (Pubitemid 40461082)
28. Lango-Warensjo A, Cardell K, Lindblom B. Haplotypes comprising subtypes of the DQB1*06 allele directed the antibody response after immunization with hepatitis B surface antigen. Tissue antigen 1998; 52(4):374-80.
29. Liang HX, Yu ZJ, Jiang HQ. Study on the association between chronic hepatitis B cirrhosis and HLA-DRB1*1301, 1302 allele. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009; 23(4):302-3.
30. Hohler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U, et al. HLA DRB1*1301 and 1302 protect against chronic hepatitis B. J Hepatol 1997; 26(30):503-7. (Pubitemid 27112714)
31. Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 2007; 14(2):841-8. (Pubitemid 350211408)
32. + T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis. Clin Exp Immunol 1998; 113(2):244-51.
33. Kacprzak-Bergman I, Nowakowska B. Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination. Arch Immunol Ther Exp 2005; 53(2):139-42. (Pubitemid 41057863)
34. Candore G, Romano GC, Anna CD, Lorenzo GD, Gervasi F, Lio D, et al. Biological basis of HLA-B8, DR3-associated progression of acquired immune deficiency syndrome. Pathol 1998; 66(1):33-7. (Pubitemid 28140600)
35. Thio CL, Thomas DL, Karacki P, Gao X, Kaslow RA, Goedert JJ, et al. Comprehensive analysis of class I and classII HLA antigens and chronic hepatitis B virus infection. J Virol 2003; 77(22):12083-7. (Pubitemid 37345173)
36. Mignini F, Streccioni V, Baldo M, Vitali M, Indraccolo U, Bernacchia G. Individual susceptibility to hexavalent chromium of workers of shoe, hide, and leather industries. Immunological pattern of HLA-B8, DR3-positive subjects. Prev Med 2004; 39(4):767-75. (Pubitemid 39194740)
37. Holzer U, Kwok WW, Nepom GT, Buckner JH. Differential antigen sensitivity and costimulatory requirements in human Th1 and Th2 antigen-specific CD4+ cells with similar TCR avidity. J Immunol 2003; 170(3):1218-23. (Pubitemid 36139486)
38. Kruger A, Adams P, Hammer J, Bocher WO, Schneider PM, Rittner C, et al. Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies. Clin Exp Immunol 2005; 140(2):325-32. (Pubitemid 40559160)
39. Murai M, Krause P, Cheroutre H, Kronenberg M. Regulatory T-cell stability and plasticity in mucosal and systemic immune systems. Mucosal Immunol 2010; 3(5):443-9.
40. Yu H, Zhu QR, Gu SQ, Fei LE. Relationship between IFN-gamma gene polymorphism and susceptibility to intrauterine HBV infection. World J Gastroenterol 2006; 12(18):2928-31. (Pubitemid 43805466)
41. Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004; 39(4):978-88. (Pubitemid 38428937)